GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prolight Diagnostics AB (NGM:PRLD) » Definitions » Price-to-Free-Cash-Flow

Prolight Diagnostics AB (NGM:PRLD) Price-to-Free-Cash-Flow : N/A (As of May. 25, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Prolight Diagnostics AB Price-to-Free-Cash-Flow?

As of today (2025-05-25), Prolight Diagnostics AB's share price is kr0.239. Prolight Diagnostics AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.09. Hence, Prolight Diagnostics AB's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Prolight Diagnostics AB's Price-to-Free-Cash-Flow or its related term are showing as below:

NGM:PRLD's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 28.34
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Prolight Diagnostics AB's Free Cash Flow per Share for the three months ended in Dec. 2024 was kr-0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was kr-0.09.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -20.20% per year.

During the past 9 years, Prolight Diagnostics AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 48.90% per year. The lowest was -20.20% per year. And the median was 5.75% per year.


Prolight Diagnostics AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for Prolight Diagnostics AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prolight Diagnostics AB Price-to-Free-Cash-Flow Chart

Prolight Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only - - - - -

Prolight Diagnostics AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Prolight Diagnostics AB's Price-to-Free-Cash-Flow

For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prolight Diagnostics AB's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Prolight Diagnostics AB's Price-to-Free-Cash-Flow falls into.


;
;

Prolight Diagnostics AB Price-to-Free-Cash-Flow Calculation

Prolight Diagnostics AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.239/-0.09
=N/A

Prolight Diagnostics AB's Share Price of today is kr0.239.
Prolight Diagnostics AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Prolight Diagnostics AB  (NGM:PRLD) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Prolight Diagnostics AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Prolight Diagnostics AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Prolight Diagnostics AB Business Description

Traded in Other Exchanges
N/A
Address
Gasverksgatan 3A, Lund, SWE, 222 29
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.